Finance

Lists
Why is 069620 up 2.19%?
Dive Deeper
069620:KRX
Daewoong Pharma
₩ 107,300.00
+2.19%
(+2,300.00) 1D
10-р сарын 19, 11:14:44 (GMT+9)  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 069620...
Open
₩ 105,300
High
₩ 107,300
Low
₩ 104,000
Mkt. cap
1.24ИН
Avg. vol.
19.18 мян
Volume
6.39 мян
Dividend
0.56%
Quarterly dividend
₩ 150
Ex-dividend date
2023 оны 12-р сарын 27
P/E ratio
6.32
52-wk high
₩ 199,400
52-wk low
₩ 101,900
EPS
₩ 16,988
Shares outstanding
11.59 сая
No. of employees
2 мян
Open
₩ 105,300
High
₩ 107,300
Low
₩ 104,000
Mkt. cap
1.24ИН
Avg. vol.
19.18 мян
Volume
6.39 мян
Dividend
0.56%
Quarterly dividend
₩ 150
Ex-dividend date
2023 оны 12-р сарын 27
P/E ratio
6.32
52-wk high
₩ 199,400
52-wk low
₩ 101,900
EPS
₩ 16,988
Shares outstanding
11.59 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
About Daewoong Pharma
CEOChang-jae Lee | Seongsoo Park
Employees1.89 мян
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
411.83Т
397.12Т
377.80Т
448.46Т
Cost of goods sold
198.11Т
185.96Т
196.61Т
199.39Т
Cost of revenue
198.11Т
185.96Т
196.61Т
199.39Т
Research and development expenses
8.31 тэрбум
139.98Т
16.11 тэрбум
14.81 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144.21Т
23.12 тэрбум
136.65Т
154.92Т
Operating expense
156.83Т
169.10Т
158.98Т
181.01Т
Total operating expenses
354.94Т
355.06Т
355.59Т
380.40Т
Operating income
56.89 тэрбум
42.06 тэрбум
22.21 тэрбум
68.07 тэрбум
Other non operating income
-1.16 тэрбум
2.77 тэрбум
1.52 тэрбум
-36.53 тэрбум
EBT including unusual items
54.73 тэрбум
68.97 тэрбум
33.97 тэрбум
21.89 тэрбум
EBT excluding unusual items
54.73 тэрбум
88.02 тэрбум
11.82 тэрбум
21.89 тэрбум
Income tax expense
7.42 тэрбум
-16.73 тэрбум
8.46 тэрбум
1.98 тэрбум
Effective tax rate
13.56%
-24.26%
24.89%
9.02%
Other operating expenses
1.17 тэрбум
1.17 тэрбум
1.88 тэрбум
1.61 тэрбум
Net income
46.37 тэрбум
89.84 тэрбум
25.90 тэрбум
33.37 тэрбум
Net profit margin
11.26%
22.62%
6.86%
7.44%
Earnings per share
-
-
-
-
Interest and investment income
-
1.12 тэрбум
1.74 тэрбум
-
Interest expense
-
-3.53 тэрбум
-8.00 тэрбум
-
Net interest expenses
-
-2.41 тэрбум
-6.26 тэрбум
-
Depreciation and amortization charges
1.77 тэрбум
1.43 тэрбум
1.15 тэрбум
7.94 тэрбум
EBITDA
69.45 тэрбум
56.04 тэрбум
38.38 тэрбум
92.95 тэрбум
Gain or loss from assets sale
-12.80 сая
-52.31 тэрбум
35.01 сая
-7.54 сая
AI content may include mistakes. Learn more
Google аппс